Tumor progression and chromatin landscape of lung cancer are regulated by the lineage factor GATA6.

Oncogene
Anna Arnal-EstapéDon X Nguyen

Abstract

Lineage selective transcription factors (TFs) are important regulators of tumorigenesis, but their biological functions are often context dependent with undefined epigenetic mechanisms of action. In this study, we uncover a conditional role for the endodermal and pulmonary specifying TF GATA6 in lung adenocarcinoma (LUAD) progression. Impairing Gata6 in genetically engineered mouse models reduces the proliferation and increases the differentiation of Kras mutant LUAD tumors. These effects are influenced by the epithelial cell type that is targeted for transformation and genetic context of Kras-mediated tumor initiation. In LUAD cells derived from surfactant protein C expressing progenitors, we identify multiple genomic loci that are bound by GATA6. Moreover, suppression of Gata6 in these cells significantly alters chromatin accessibility, particularly at distal enhancer elements. Analogous to its paradoxical activity in lung development, GATA6 expression fluctuates during different stages of LUAD progression and can epigenetically control diverse transcriptional programs associated with bone morphogenetic protein signaling, alveolar specification, and tumor suppression. These findings reveal how GATA6 can modulate the chromatin...Continue Reading

References

Apr 7, 1995·The Journal of Biological Chemistry·K IkedaJ A Whitsett
Jul 13, 2002·American Journal of Physiology. Lung Cellular and Molecular Physiology·Cong LiuJeffrey A Whitsett
Oct 28, 2003·The American Journal of Pathology·Alain C BorczukCharles A Powell
Nov 17, 2005·Cancer Research·Erica L JacksonTyler Jacks
Apr 14, 2006·BMC Developmental Biology·Chhinder P SodhiStephen A Duncan
Jun 10, 2008·Nature Genetics·Yuzhen ZhangEdward E Morrisey
Apr 8, 2011·Nature·Monte M WinslowTyler Jacks
Jun 7, 2011·American Journal of Respiratory and Critical Care Medicine·Jeffrey A WhitsettYutaka Maeda
Nov 8, 2011·Genes & Development·Kenneth S Zaret, Jason S Carroll
Mar 1, 2012·Proceedings of the National Academy of Sciences of the United States of America·Lin LinDavid G Beer
Mar 14, 2012·Proceedings of the National Academy of Sciences of the United States of America·Xia XuMark W Onaitis
Jun 7, 2013·Journal of Human Genetics·Hiroshi Kimura
Aug 8, 2013·The Journal of Clinical Investigation·Christina E BarkauskasBrigid L M Hogan
Dec 25, 2013·Nature Reviews. Genetics·Taiping Chen, Sharon Y R Dent
Mar 4, 2014·Proceedings of the National Academy of Sciences of the United States of America·Kate D SutherlandAnton Berns
Apr 26, 2014·The Journal of Clinical Investigation·Yanan YangJonathan M Kurie
Jul 25, 2014·Nature Reviews. Cancer·Zhao ChenKwok-Kin Wong
Aug 1, 2014·Nature·UNKNOWN Cancer Genome Atlas Research Network
Mar 31, 2015·Oncogene·W K C Cheung, D X Nguyen
Sep 6, 2015·Genes & Development·Carman Man-Chung LiTyler Jacks
Feb 24, 2016·Cell·Charles J DavidJoan Massagué
Aug 9, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Haichuan HuHaiquan Chen
Aug 15, 2017·Nature Reviews. Genetics·Yaser Atlasi, Hendrik G Stunnenberg
Jun 12, 2018·The Journal of Clinical Investigation·Chia-Min LiaoPaul Gadue

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Datasets Mentioned

BETA
GSE124604

Methods Mentioned

BETA
PCR
immunoprecipitation
ChIP-seq
mechanical dissociation

Software Mentioned

Prism
GraphPad
Metacore
ImageJ

Related Concepts

Related Feeds

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.